Table 1. Characteristics of the cohort (n = 92).
| Mean | SD | ||
| Age | 73.6 | 6.7 | |
| Disease duration (years) | 7.9 | 5.7 | |
| MDS-UPDRS III (motor examination) | 28.1 | 15.1 | |
| MDS-UPDRS IV | 4.5 | 5.1 | |
| NMS-Quest | 11.5 | 4.8 | |
| LEDD | 670 | 436 | |
| Number of drugs per day | 6.2 | 3.0 | |
| BDI total | 13.7 | 7.6 | |
| BMI (kg/m2) | 25.7 | 3.4 | |
| median | IQR | ||
| Hoehn and Yahr stage | 3.0 | 1.0 | |
| MNA sum score | 12.0 | 3.0 | |
| n | % | ||
| Gender | Female | 40 | 43.5 |
| Male | 52 | 56.5 | |
| Marital status | Married | 70 | 76.1 |
| Single/divorced/widowed | 22 | 23.9 | |
| Nutrition status | malnutrition | 6 | 6.5 |
| risk of malnutrition | 36 | 39.1 | |
| normal nutrition | 50 | 54.3 | |
IQR, interquartile range; MNA, Mini Nutritional Assessment Short Form; MDS-UPDRS, Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale; NMS-Quest, revised Non-Motor Symptoms Questionnaire; LEDD, levodopa equivalent daily dose; MoCa, Montreal Cognitive Assessment; BDI, Beck Depression Inventory; BMI, Body mass index (BMI).